Related Experiment Videos

Ten-year follow-up on Dutch orthopaedic blood management (DATA III survey)

M C Struijk-Mulder1, W G Horstmann, C C Verheyen

  • 1Department of Orthopaedic Surgery and Traumatology, Isala Clinics, Postbus 10400, 8000 GK, Zwolle, The Netherlands, mcstruijk@gmail.com.

Insights

Dutch hospitals continue to widely use erythropoietin and postoperative autologous retransfusion for hip and knee replacements. However, effective blood management strategies like tranexamic acid remain underutilized.

Area of Science:

  • Orthopaedic Surgery
  • Transfusion Medicine
  • Patient Blood Management

Background:

  • Allogeneic blood transfusions frequently complicate hip and knee arthroplasties.
  • Assessing current perioperative blood-saving measures is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the contemporary use of perioperative blood-saving techniques in Dutch orthopaedic departments.
  • To compare current practices with data from 5 and 10 years prior.

Main Methods:

  • A follow-up survey was distributed to all Dutch hospital orthopaedic surgery departments.
  • Data collected were compared to previous survey results from 2007 and 2012.

Main Results:

  • Erythropoietin use is common, often replacing preoperative autologous blood donation.
  • Intraoperative autologous retransfusion rates remain largely unchanged for revision arthroplasty.
  • Postoperative autologous retransfusion is utilized by most departments for primary and revision hip/knee arthroplasty.

Conclusions:

  • Erythropoietin, normothermia, and postoperative autologous retransfusion are standard in Dutch orthopaedic departments for hip and knee arthroplasty.
  • Intraoperative retransfusion is primarily employed in hip revision arthroplasty.
  • Effective blood management strategies, such as tranexamic acid, are not widely adopted.
Abstract